Sorafenib is a clinically useful multiple kinase inhibitor for the treatment of kidney cancer. liver cancer and acute myelocytic leukemia. while it has shown weak efficacy in suppressing breast cancer. Since sirtuin2 (SIRT2) is an important epigenetic regulator and associated with several cancer types including breast cancer. https://oxfordshopes.shop/product-category/ladies-tops/